NFKB1 and cancer: Additionally, the ~2,6 kb NKILA lncRNA was found to downregulate cancer-related inflammation pathways by binding to the p65 component of the NF-κB complex and masking the phosphorylation sites responsible for IκB-mediated release of the NF-κB complex in the nucleus [23].